These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. [Management of autoimmune thrombocytopenic purpura: a prospective study of 147 children from the regional network RHémaP]. Le Meignen M, Mossler P, Mates M, Mathey C, Hass A, Monpoux F, Faverge B, Fortier G, Nguyen J, Belahbib L, Coache C, Chamoulli JM, Moulène E, Sirvent N, Michel G, Chambost H. Arch Pediatr; 2008 Sep; 15(9):1398-406. PubMed ID: 18676127 [Abstract] [Full Text] [Related]
43. Characteristics and management of primary and other immune thrombocytopenias: Spanish registry study. Palau J, Sancho E, Herrera M, Sánchez S, Mingot ME, Upegui RI, Rodríguez Salazar MJ, de la Cruz F, Fernández MC, González López TJ, Hernández JJ, Ríos E, López-Fernández MF, García M, Hernández JÁ, Sanz MA. Hematology; 2017 Sep; 22(8):484-492. PubMed ID: 28415913 [Abstract] [Full Text] [Related]
45. A Study of Human Killer Cell Immunoglobulin-Like Receptor and Multidrug Resistance Gene Polymorphisms in Children With Immune Thrombocytopenia. El-Beblawy NM, Elbarbary NS, Kamal TM, Mahmoud PM. Clin Appl Thromb Hemost; 2016 Jul; 22(5):429-40. PubMed ID: 25792670 [Abstract] [Full Text] [Related]
51. Predictors of remission in children with newly diagnosed immune thrombocytopenia: Data from the Intercontinental Cooperative ITP Study Group Registry II participants. Bennett CM, Neunert C, Grace RF, Buchanan G, Imbach P, Vesely SK, Kuhne T. Pediatr Blood Cancer; 2018 Jan; 65(1):. PubMed ID: 28792679 [Abstract] [Full Text] [Related]